Skip to main content
. 2020 Oct 8;11:582936. doi: 10.3389/fendo.2020.582936

Figure 3.

Figure 3

Type 2 diabetes management therapeutics in Covid-19. The six main classes of glucose-lowering drugs summarized according to their reported effect on inflammation, cardiovascular disease, respiratory disease and critically ill patient safety.

HHS Vulnerability Disclosure